The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

1.63%Dividend Yield

Jun 26

$0.31

Mar 26

$0.28

Dec 25

$0.59

Sep 25

$0.31

Jun 25

$0.31

10Y Growth

13.18%

5Y Growth

8.45%

3Y Growth

20.25%

1Y Growth

-0.48%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IHE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Invesco Pharmaceuticals

PJP

Mkt Cap0

PowerShares Dynamic Pharmaceuticals ETF, directly competes by investing in U.S. pharmaceutical companies.

State Street SPDR S&P Pharmaceuticals

XPH

Mkt Cap0

SPDR S&P Pharmaceuticals ETF, tracks a similar S&P Pharmaceuticals Select Industry Index, making it a direct competitor.

Fidelity MSCI Health Care Index

FHLC

Mkt Cap0

Fidelity MSCI Health Care Index ETF, includes a significant allocation to pharmaceuticals, competing in the healthcare sector.

Vanguard Health Care

VHT

Mkt Cap0

Vanguard Health Care ETF, has a broad exposure to the healthcare sector, including pharmaceuticals, making it a competitor.

iShares U.S. Healthcare

IYH

Mkt Cap0

iShares U.S. Healthcare ETF, competes by investing in U.S. healthcare stocks, including pharmaceuticals.

State Street Health Care Select Sector SPDR

XLV

Mkt Cap0

Health Care Select Sector SPDR Fund, competes as it includes major pharmaceutical companies in its holdings.

VanEck Biotech

BBH

Mkt Cap0

VanEck Vectors Biotech ETF, while focused on biotech, it competes due to overlap in pharmaceuticals and healthcare.

Invesco Biotechnology & Genome

PBE

Mkt Cap0

Invesco Dynamic Biotechnology & Genome ETF, competes indirectly through its focus on biotech, which includes companies involved in pharmaceuticals.

Holdings

Regions

Sectors

About

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.

CEO

Country

United States

ISIN

US4642888360

Listings

0 Comments

Share your thoughts

FAQ

What is iShares U.S. Pharmaceuticals stock price today?▼

The current price of IHE is $91.08 USD — it has decreased by -0.47% in the past 24 hours. Watch iShares U.S. Pharmaceuticals stock price performance more closely on the chart.

What is iShares U.S. Pharmaceuticals stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange iShares U.S. Pharmaceuticals stocks are traded under the ticker IHE.

Is iShares U.S. Pharmaceuticals stock price growing?▼

IHE stock has risen by +2.86% compared to the previous week, the month change is a +5.88% rise, over the last year iShares U.S. Pharmaceuticals has showed a +43.21% increase.

Does iShares U.S. Pharmaceuticals pay dividends?▼

Yes, IHE dividends are paid quarterly. The last dividend per share was 0.28 USD. As of today, Dividend Yield (FWD)% is 1.63%.

In which sector is iShares U.S. Pharmaceuticals located?▼

iShares U.S. Pharmaceuticals operates in the Other sector.

When did iShares U.S. Pharmaceuticals complete a stock split?▼

The last stock split for iShares U.S. Pharmaceuticals was on March 07, 2024 with a ratio of 3:1.